Your browser doesn't support javascript.
loading
Carboplatin desensitization - simplified 4-step 2-bag method.
Kintzel, Polly E; Gressel, Gregory M; Van Rossum, Brett T; Hillaker, Kristin N; Ice, Lauren L; Eastman, Jacqueline J.
Afiliación
  • Kintzel PE; Clinical Pharmacist Specialist Adult Oncology-Emeritus, Corewell Health West, Grand Rapids, MI, USA.
  • Gressel GM; Director of Gynecologic Cancer Research, Corewell Health Medical Group West, Grand Rapids, MI, USA.
  • Van Rossum BT; Clinical Pharmacist Specialist for Inpatient Oncology, Corewell Health West, Grand Rapids, MI, USA.
  • Hillaker KN; Clinical Pharmacist, Corewell Health West, Grand Rapids, MI, USA.
  • Ice LL; Clinical Pharmacist Specialist for Cancer Health, Corewell Health West, Grand Rapids, MI, USA.
  • Eastman JJ; Department of Allergy/Immunology, Corewell Health Medical Group West, Grand Rapids, MI, USA.
J Oncol Pharm Pract ; 30(4): 759-766, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38470451
ABSTRACT

INTRODUCTION:

Our cancer program adopted a method for carboplatin desensitization (4-step 2-bag method) that administers the same intensity of drug exposure with a simplified approach to product management in comparison to a published protocol (4-step 4-bag method).

METHODS:

The intensity of carboplatin administration for 11,000, 1100, 110, and 11 dilutions and concomitant fluid administration were compared for the 4-step 2-bag (bags A, B) and 4-step 4-bag (bags 1, 2, 3, 4) methods. Pharmacy preparation of bags A and B is described. A succinct overview of the desensitization procedure is provided. Important considerations germane to pharmacy practice are presented. Chart review of patients who underwent carboplatin desensitization with the 4-step 2-bag method between 7/13/2021 and 11/22/2023 was performed to demonstrate institutional use.

RESULTS:

The 4-step 2-bag method delivers similar rates of drug intensity from start of desensitization to completion of the planned dose as the previously published 4-step 4-bag method. Accuracy of regimen-based dose administration is assured by infusion of bag B contents irrespective of infusion interruptions or rate changes necessitated by patient tolerance. Bag A provides the 11000 dilution in a pharmaceutically elegant manner using administration rates and volumes compatible with clinical practice.

CONCLUSION:

The 4-step 2-bag method for carboplatin desensitization administers controlled drug titration corresponding to 11000, 1100, 110, and 11 dilutions for dose administration using two compounded admixture bags. Inaugural clinical use of the 4-step 2-bag method for carboplatin desensitization at our healthcare facility has proceeded with expected patient tolerance.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carboplatino / Desensibilización Inmunológica / Antineoplásicos Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Oncol Pharm Pract Asunto de la revista: FARMACIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carboplatino / Desensibilización Inmunológica / Antineoplásicos Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Oncol Pharm Pract Asunto de la revista: FARMACIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos